AHA Guidelines: Bacterial
Endocarditis Prophylaxis
See the new SBE Prophylaxis 2008
OLD
American Heart Association SBE Guidelines- JAMA 1997;277:1794
|
Table 1: Cardiac Conditions Associated With Endocarditis
Table 2: Dental Procedures and Endocarditis Prophylaxis
Table 3: Other Procedures and Endocarditis Prophylaxis
Table 4: Prophylactic Regimens for Dental, Oral, Respiratory Tract, or Esophageal Procedures
Table 5: Prophylactic Regimens for Genitourinary/Gastrointestinal (Excluding Esophageal) Procedures
Endocarditis prophylaxis recommended
|
Endocarditis prophylaxis NOT recommended:
Negligible-risk category (no greater risk than the general population) |
||
---|---|---|---|
High-risk category |
|
||
|
|||
Moderate-risk category | |||
|
Endocarditis prophylaxis recommended1 | Endocarditis prophylaxis not recommended |
---|---|
|
|
1 Prophylaxis is recommended for patients with high- and moderate-risk cardiac conditions. 2 This includes restoration of decayed teeth (filling cavities) and replacement of missing teeth. 3 Clinical judgment may indicate antibiotic use in selected circumstances that may create significant bleeding |
Endocarditis prophylaxis recommended | Endocarditis prophylaxis NOT recommended |
---|---|
Respiratory tract:
|
Respiratory tract:
|
Gastrointestinal
tract1:
|
Gastrointestinal tract:
|
Genitourinary tract:
|
Genitourinary tract:
-In uninfected tissue:
|
Other:
|
1 Prophylaxis is recommended for high-risk patients; it is optional for medium-risk patients. 2 Prophylaxis is optional for high-risk patients 3 Prophylaxis is optional for high-risk patients |
Situation | Agent | Regimen1 |
---|---|---|
Standard general prophylaxis | Amoxicillin |
|
Unable to take oral medications | Ampicillin |
|
Allergic to penicillin | Clindamycin or |
|
Cephalexin2 or cefadroxilb or |
|
|
Azithromycin or
clarithromycin |
|
|
Allergic to penicillin and unable to take oral medications | Clindamycin or |
|
Cefazolin2 |
|
1 Total children's dose should not exceed adult dose 2 Cephalosporins should not be used in individuals with immediate-type hypersensitivity reaction (urticaria, angioedema, or anaphylaxis) to penicillins |
Situation | Agents | Regimen1,2 |
---|---|---|
High-risk patients | Ampicillin plus gentamicin |
|
High-risk patients allergic to ampicillin/amoxicillin | Vancomycin plus gentamicin |
|
Moderate-risk patients | Amoxicillin or ampicillin |
|
Moderate-risk patients allergic to ampicillin/amoxicillin | Vancomycin |
|
1 Total children's dose should not exceed adult dose 2 No second dose of vancomycin or gentamicin is recommended. |
Physicians' Recommendations to Patients for Use of Antibiotic Prophylaxis
to Prevent Endocarditis
Todd B. Seto, etc.
JAMA. July 5,
2000;284:68-71
Guidelines updated for infective endocarditis prophylaxis in valvular heart disease
The American College of Cardiology and American Heart Association have updated their joint guidelines for preventing infective endocarditis (IE) in valvular heart disease.
The update, published in the Aug. 19, 2008 Journal of the American College of Cardiology, is based on new evidence that has emerged since the 2006 ACC/AHA Guidelines for the Management of Valvular Heart Disease were published. Major changes include:
* There are now no Class I recommendations for IE prophylaxis in patients with valvular heart disease;
* Antibiotic IE prophylaxis is no longer indicated in patients with aortic stenosis, mitral stenosis, or symptomatic or asymptomatic mitral valve prolapse. It is also not indicated in adolescents and young adults with native heart valve disease;
* It's not recommended to administer antibiotics solely to prevent IE in patients undergoing a genitourinary (GU) and gastrointestinal (GI) tract procedure. Nor is it recommended solely on the basis of an increased lifetime risk of IE; and
* IE prophylaxis for dental procedures should only be used in patients with underlying cardiac conditions associated with the highest risk for adverse outcomes, such as prosthetic valves or prior IE. In those cases, prophylaxis is reasonable for procedures that involve manipulating gingival tissue or the periapical region of teeth, or perforating oral mucosa.
The guidelines were revised for several reasons. IE is more likely to result from frequent exposure to random bacteremias associated with daily activities than from bacteremia caused by a dental, GI tract or GU procedure. As well, the number of IE cases preventable by prophylaxis in patients undergoing those procedures is "exceedingly small," the article said. Also, the risk of adverse effects caused by antibiotics exceeds any benefit from prophylactic antibiotics.
Physicians should be prepared to discuss the updated guidelines with patients as the changes may cause some concern, the article said. Some doctors and patients may still be more comfortable continuing with prophylaxis for IE in certain circumstances; in those cases, the doctor should ensure that the risks associated with antibiotics are minor before prescribing them.